Immunopathogenesis and treatment of myasthenia gravis
- 1 May 1987
- journal article
- review article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 7 (3) , 187-197
- https://doi.org/10.1007/bf00915723
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- The Auto‐Anti‐Idiotypic Route to Antireceptor AntibodiesaAnnals of the New York Academy of Sciences, 1986
- Suppressor T cells in myasthenia gravis and antibodies to acetylcholine receptorAnnals of Neurology, 1986
- Depletion of helper/inducer T cells after thymectomy in myasthenic patientsClinical Immunology and Immunopathology, 1983
- Immunohistological studies of the thymus in myasthenia gravisJournal of Neuroimmunology, 1982
- Thymus Cells in Myasthenia Gravis Selectively Enhance Production of Anti-Acetylcholine-Receptor Antibody by Autologous Blood LymphocytesNew England Journal of Medicine, 1981
- Genetic control of suppressor lymphocyte function in myasthenia gravis: Relationship of impaired suppressor function to and cold reactive lymphocytotoxic antibodiesClinical Immunology and Immunopathology, 1979
- Identification of Two Serum Components Regulating the Expression of T-Lymphocyte Function in Childhood Myasthenia GravisNew England Journal of Medicine, 1979
- Myasthenia GravisNew England Journal of Medicine, 1978
- Plasmapheresis and Immunosuppressive Drug Therapy in Myasthenia GravisNew England Journal of Medicine, 1977
- Thymic Muscle Cells Bear Acetylcholine Receptors: Possible Relation to Myasthenia GravisScience, 1977